Concepedia

O Mast

OM

4

Publications

139

Citations

4

H-Index

2001

Active since

Affiliations

Bayer (Germany)(Current)

Institute of Empirical Health Economics

O Mast is an author at Bayer (Germany) specializing in medicine, antibiotics, and drug resistance.

Top concepts

MedicineAsthmaAntibioticsDrug ResistanceHospital MedicineInfection ControlPulmonary DiseasePulmonary FibrosisPulmonary MedicineRespiratory Diseases

Publications per year

2001–2003

4

Publications

4

Nosocomial Pneumonia: A Cost-of-Illness Analysis

Eva Susanne Dietrich, M Demmler, Gabi Schulgen et al. · Infection · 2002 · 58 citations · Full text

Healthcare-associated Infection, Nosocomial Pneumonia, Infection Control +3

Treatment Outcomes in Acute Exacerbations of Chronic Bronchitis: Comparison of Macrolides and Moxifloxacin from the Patient Perspective

J. Lorenz, I-M Thate-Waschke, O Mast et al. · Journal of International Medical Research · 2001 · 39 citations

Asthma, Inflammatory Lung Disease, Moxifloxacin Group +16

Flupenthixol versus Risperidone: Subjective Quality of Life as an Important Factor for Compliance in Chronic Schizophrenic Patients

Inés Hertling, Michael Philipp, Alexander Dvorak et al. · Neuropsychobiology · 2003 · 28 citations

[Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].

Reinhard Rychlik, T Pfeil, dos Santos da Rocha Tarciso Daniel et al. · PubMed · 2001 · 14 citations

Rows per page

1–4 of 4